Risk of atrial arrhythmias in patients with ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy
Heart Rhythm · 2024-02 · 21 (2) · 133-140
DOI: 10.1016/j.hrthm.2023.11.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2024-02. Verfasst von Erica S Zado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Atrial Flutter, Arrhythmogenic Right Ventricular Dysplasia, Atrial Fibrillation, Tachycardia, Ventricular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: In arrhythmogenic right ventricular cardiomyopathy (ARVC), risk of atrial arrhythmias (AAs) persists after ventricular tachycardia (VT) ablation. OBJECTIVE: The purpose of this study was to determine the type, prevalence, outcome, and risk correlates of AA in ARVC in patients undergoing VT ablation. METHODS: Prospectively collected procedural and clinical data on ARVC patients undergoing VT ablation were analyzed. Risk score for typical atrial flutter was determined from univariate logistic regression analysis. RESULTS: Of 119 consecutive patients with ARVC and VT ablation, 40 (34%) had AA: atrial fibrillation (AF) in 31, typical isthmus-dependent atrial flutter (AFL) in 27, and atrial tachycardia/atypical flutter (AT) in 10. Seventeen patients (43%) with AA experienced inappropriate defibrillator therapy, with 15 patients experiencing shocks. Ablation was performed for typical AFL in 21 (53%), AT in 5 (13%), and pulmonary vein isolation for AF in 4 (10%) patients and prevented AA in 78% and all AFL during additional mean follow-up of 65 months. Risk score for typical flutter included age >40 years (1 point), ≥moderate right ventricular dysfunction (2 points), ≥moderate tricuspid regurgitation (2 points), ≥moderate right atrial dilation (2 points), and right ventricular volume >250 cc (3points), with score >4 identifying 50% prevalence of typical flutter. CONCLUSION: AAs are common in patients with ARVC and VT, can result in inappropriate implantable cardioverter-defibrillator shocks, and typically are controlled with atrial ablation. A risk score can be used to identify patients at high risk for typical AFL who may be considered for isthmus ablation at the time of VT ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
- Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: francis.marchlinski@pennmedicine.upenn.edu.
Zitieren
APA
Zado, E. S., Garg, L., Tschabrunn, C., Santangeli, P., Hyman, M., Kumareswaran, R., Arkles, J., & Marchlinski, F. E. (2024). Risk of atrial arrhythmias in patients with ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm, 21(2), 133-140. https://doi.org/10.1016/j.hrthm.2023.11.005
Vancouver
Zado ES, Garg L, Tschabrunn C, Santangeli P, Hyman M, Kumareswaran R, et al. Risk of atrial arrhythmias in patients with ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2024;21(2):133-140. doi:10.1016/j.hrthm.2023.11.005
BibTeX
@article{Zado2024,
author = {Zado, Erica S and Garg, Lohit and Tschabrunn, Cory and Santangeli, Pasquale and Hyman, Matthew and Kumareswaran, Ramanan and Arkles, Jeffrey and Marchlinski, Francis E},
title = {Risk of atrial arrhythmias in patients with ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy},
journal = {Heart Rhythm},
year = {2024},
volume = {21},
number = {2},
pages = {133--140},
doi = {10.1016/j.hrthm.2023.11.005}
}
EUVIMED